ARTICLE | Clinical News
Affitech, Peregrine preclinical data
November 16, 2009 8:00 AM UTC
In a mouse model of breast cancer, r84 inhibited cancer growth at least as well as Avastin bevacizumab and Sutent sunitinib and was superior to both drugs in limiting the presence of immunosuppressi...